MARKET

RLAY

RLAY

Relay Therapeutics, Inc.
NASDAQ
13.53
-0.13
-0.95%
After Hours: 13.32 -0.21 -1.56% 19:13 05/22 EDT
OPEN
13.52
PREV CLOSE
13.66
HIGH
13.95
LOW
13.40
VOLUME
5.36M
TURNOVER
--
52 WEEK HIGH
17.32
52 WEEK LOW
2.750
MARKET CAP
2.59B
P/E (TTM)
-8.6454
1D
5D
1M
3M
1Y
5Y
1D
Citizens biotech analysts hold a dinnermeeting at ASCO
TipRanks · 1d ago
Relay Therapeutics Announces Major Underwritten Equity Offering
TipRanks · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
Reuters · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
Reuters · 2d ago
Advance Auto Parts Posts Upbeat Q1 Earnings, Joins IBM, Ralph Lauren And Other Big Stocks Moving Higher On Thursday
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Reuters · 2d ago
BUZZ-Relay Therapeutics gains after $275 mln equity raise
Reuters · 2d ago
Relay Therapeutics: Encouraging Data, Competitive Risks (Downgrade)
Seeking Alpha · 2d ago
More
About RLAY
Relay Therapeutics, Inc. is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease. The Company's Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company's lead clinical asset, zovegalisib (RLY-2608), is the pan-mutant selective PI3Ka inhibitor to enter clinical development and is currently in a Phase 3 clinical trial (ReDiscover-2) in HR+/HER2- metastatic breast cancer. Zovegalisib is also being investigated in a group of genetic disease indications called PI3Ka-driven vascular anomalies. Its pipeline also includes programs for NRAS-driven solid tumors and Fabry disease.

Webull offers Relay Therapeutics Inc stock information, including NASDAQ: RLAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RLAY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RLAY stock methods without spending real money on the virtual paper trading platform.